NewsReal LifeLydia Burgess-Gamble has helped a sick woman in her twenties after they were genetically matched
Tuesday, 22nd October 2019, 10:38 am
Lydia Burgess-Gamble felt a lump in her throat when she got the letter saying her stem cells were a match for someone sick.
The 42-year-old had signed up to the register to be a donor almost three years earlier and hadn't given it much thought since.
Ahead of her 40th birthday, she'd wanted to do something altrusistic. Now she had the chance to potentially save someone's life who was battling a blood cancer or blood disorder.
Donating stem cells today is almost as easy as giving blood. "It was a straightforward and painless process and being able to relax and read a book for a few hours was a luxury," she said.
Patients face difficult odds
Every 20 minutes someone in the UK is diagnosed with a blood cancer, such as leukaemia, myeloma or lymphoma. That's more than 30,000 people a year. Worldwide, it's one every 30 seconds.
Patients suffering with these types of cancers can have their bone marrow damaged by the cancer itself, or from chemotherapy and radiation treatments. A stem cell transplant lets the new stem cells take over from the damaged marrow so the body can produce healthy, cancer-free blood cells.
Even though there are over 27 million people on the worldwide register, this isnt enough, according to charity DKMS. At any one time there are around 2,000 people in the UK in need of a transplant.
Matching donors and patients isnt easy because it's determined by tissue type, not blood group. There are thousands of different human leukocyte antigen (HLA) characteristics, in millions of combinations. Doctors look to relatives for a match but two out of three of those in need are unable to find one, and so must rely on the generosity of strangers.
Most donations are day cases at hospital
Lydia, an environmental research scientist from Brighton, became aware of the process involved through a Facebook post. "A friend shared an appeal for a loved one who needed a donor," she said. "I remember watching a documentary about donating bone marrow in the 90s and I hadn't realised it mainly doesn't involve an invasive procedure until I read this post."
The donation usually involves a nonsurgical procedure called peripheral blood stem cell (PBSC) donation for around 90 per cent of all cases, which is the method Lydia used.
With this method, blood is taken from one of the donors arms and a machine extracts the blood stem cells from it. The donors blood is then returned to their body through their other arm. It is an outpatient procedure that usually takes four to six hours.
'I had no side effects, other than I felt a little more tired than usual the next day'
Lydia Burgess-Gamble
This procedure doesn't "deplete" a donor's supply of stem cells, as a donor's stem cells will completely replenish themselves within two to four weeks afterwards.
"I had no side effects, other than I felt a little more tired than usual the next day but within 24 hours I was completely back to normal," said Lydia.
"All I know about my recipient is that it's a woman in her twenties who lives in Turkey. I'd love to make contact one day. I'm not expecting anything but I'm hoping she gets well and we may be able to meet."
The other 10 per cent of donations are made through bone marrow, where donors give cells from the bone marrow in their pelvis. This is under general anaesthetic so that no pain is experienced. The collection itself takes one to two hours and most donors return to their regular activities within a week. Two weeks after donation, your bone marrow will have recovered fully, and the hip bone will have fully healed within six weeks.
Donating: the process
To become a potential blood stem cell donor first check your eligibility on the DKMS website and request a swab kit for your cheek.
Complete the swabs posted to you at home and send them back. Then yourtissue type will be analysed and your details will be added to the UK stem cell registry. Your details can be searched for a genetic match for people all over the world who need a second chance at life.
The odds are you may never be called upon, but if you are, you will have a blood test at your local GP or hospital and will be asked to complete a medical questionnaire and consent form. If you're deemed fit and healthy enough, you'll have a further medical assessment and consultation at a specialist collection centre (where you will later donate your blood stem cells).
It's important to read about the methods used to collect blood stem cells PBSC and bone marrow donation because if youre on the register, you should be willing to donate in either way. The method will be determined by what the doctors believe will be best for the patient. However, you will of course always have the final decision on whether you are happy to proceed.
When a donor is matched with a patient, DKMS will cover the costs (including any travel, meals, or accommodation expenses that may be necessary and lost wages if you are not covered by your employer).
Your blood stem cells will never be stored, they last for around 72 hours and are delivered straight to the person in need by a special courier.
You will be allowed to meet the patient, if they consent, eventually UK guidelines state this can happen two years after the donation (and tules vary by country).Contact through anonymous letters can be established before this time via DKMS.
You will stay on the register until your 61st birthday.
See the rest here:
'I've potentially saved a stranger's life by donating my blood stem cells and it was painless' - inews
- Stem Cell Manufacturing Market 2021 | Research With Size, Growth, Manufacturers, Key Segment, Analysis, Development Status, Segments and 2027... - February 19th, 2021
- Tissue regeneration: Reserve or reverse? - Science Magazine - February 19th, 2021
- Global Scaffold Technology Market Is Expected to Reach USD 2.16 billion by 2028 : Fior Markets - GlobeNewswire - February 19th, 2021
- Recombinant Growth Factors to Account for Over 45% of Overall Demand through 2031: Persistence Market Research - PRNewswire - February 19th, 2021
- The Untapped Potential of Cell and Gene Therapy - AJMC.com Managed Markets Network - February 19th, 2021
- Century Therapeutics Significantly Expands Capabilities with New Operational, Laboratory and Manufacturing Facilities in Pennsylvania and New Jersey -... - February 19th, 2021
- Cell Therapy Processing Market To Grow Value $12062 Million By 2026 | Latest Research Report - PharmiWeb.com - February 19th, 2021
- Global Stem Cell Therapy Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 KSU | The Sentinel... - February 19th, 2021
- Humanized Mouse and Rat Model Market: Increased development of monoclonal antibodies and improved healthcare to drive the market - BioSpace - February 19th, 2021
- Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings - PRNewswire - February 19th, 2021
- Global Apoptosis Assays Market Estimated To Expand At A Robust CAGR By 2027||Promega, Abcam plc, Research And Diagnostic Systems, Inc., Sartorius AG,... - February 19th, 2021
- Tibidabo Scientific Industries Strengthens its Core Executive Team with the Appointment of Industry Veteran, John LaViola as Chief Technology Officer... - February 19th, 2021
- Global Cell Expansion Market Value Projected to Expand by 2021-2026 | Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Group Ltd., Becton,... - February 19th, 2021
- How Irish medtech came to thrive - Med-Tech Innovation - February 19th, 2021
- Translational Regenerative Medicine Market: Immunotherapy is projected to be the fastest growing segment during the forecast period - BioSpace - February 11th, 2021
- Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First Off-the-shelf Genomic Medicines - Business Wire - February 11th, 2021
- Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies - PRNewswire - February 11th, 2021
- Global Biopreservation Market Is Expected to Reach USD 7.67 Billion by 2028 : Fior Markets - GlobeNewswire - February 11th, 2021
- Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater... - February 11th, 2021
- Stem Cell Therapy Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast By 2029: Osiris Therapeutics, NuVasive, Chiesi... - February 11th, 2021
- 2020 Outlook on the Global Singlecell Technology Industry - Market Size was Over $800 Million in 2019 - ResearchAndMarkets.com - Business Wire - February 11th, 2021
- Stem Cell Cryopreservation Equipments Market Size Report: Strategies of Key Manufacturers, Project Investment of New Industries: Chart, Worthington... - February 11th, 2021
- Seattle Cancer Care Alliance Celebrates 20 Years of Innovation in Cancer Treatment and Care - Business Wire - February 11th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 11th, 2021
- Researchers curb local immune response in horses receiving stem cell injury therapy - Horsetalk - February 7th, 2021
- Biobanking Market Report Research and Global Outlook 2021 to 2025 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - February 7th, 2021
- Animal Stem Cell Therapy Market By Product Type (Dogs, Horses) And By End-Users/Application (Veterinary Hospitals, Research Organizations) Market... - February 6th, 2021
- Stem Cell Assay Market Share, Demand, Manufacturers and Forecast till 2027 | Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent... - February 6th, 2021
- Global Apoptosis Assays Market Set To Grow At Healthy CAGR Of 11.10% By 2027||Abcam plc, Research And Diagnostic Systems, Inc., Sartorius AG, Biotium,... - February 6th, 2021
- Jill Biden signals White House resolve on cancer research: This is the fight of our lives - The Cancer Letter - February 6th, 2021
- Tiny sensor technique reveals cellular forces involved in tissue generation - Brown University - February 6th, 2021
- Global Stem Cell Partnering Terms and Agreements Directory 2020: Company AZ, Headline Value, Stage of Development at Signing, Deal Component Type,... - February 6th, 2021
- Perales Examines the Impact of COVID-19 on Recipients of Cellular Therapies for Cancer - OncLive - February 6th, 2021
- Stem Cell Market is Expected to Grow with an Impressive CAGR till 2027 | Players Vcanbio, Boyalife, Beikebiotech KSU | The Sentinel Newspaper - KSU... - February 6th, 2021
- Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the... - February 4th, 2021
- Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technology - PRNewswire - February 4th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure - Yahoo Finance UK - February 4th, 2021
- Biobanks Market | Prominent Factors Analysis that will Help in Reshaping the Market Growth - BioSpace - February 4th, 2021
- Alexion Reports Fourth Quarter and Full Year 2020 Results - BioSpace - February 4th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Size, Share, Analysis, Growth Driver and Industry Segments by 2027 KSU | The... - February 4th, 2021
- Transfection Technologies Market Size 2020 | Global Business Strategies, Growing CAGR of 20.0%, Industry Revenue, Opportunities-Aldrich Co Thermo... - February 4th, 2021
- Global Apoptosis Assays Market Report 2020: Apoptosis Assay Kits Lead the Demand with 42.5% Share - Forecast to 2026 - GlobeNewswire - February 4th, 2021
- Global Hematopoietic Stem Cells Transplantation Market 2020 Industry Scenario, Strategies, Growth Factors and Forecast to 2025 KSU | The Sentinel... - February 4th, 2021
- Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (XSCID) - GlobeNewswire - February 4th, 2021
- Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell... - February 4th, 2021
- People With Cancer Should Receive COVID-19 Vaccine, Experts Say - Cancer Health Treatment News - February 4th, 2021
- Adipose Tissue-Derived Stem Cells (ADSCS) Market is Projected to Grow Massively in Near Future The Courier - The Courier - February 4th, 2021
- Healthcare Inventory Management Market: Rising Research and Development is Anticipated to Drive the Market - BioSpace - January 30th, 2021
- Cell and Gene Therapy Firms Gear up to Revolutionize Manufacturing - Labiotech.eu - January 30th, 2021
- Latest Research and Industry Trends of Cell and Tissue Culture Supplies Market Forecast 2027 Stemcell Technologies, Wheaton Industries, GE Healthcare ... - January 30th, 2021
- 5 People in the BioHealth Capital Region You Should Know In 2021 - BioBuzz - January 30th, 2021
- Global CAR-T Therapy Market Opportunities and Strategies Report 2020: COVID-19 Impact and Recovery - Forecast to 2030 - GlobeNewswire - January 30th, 2021
- Their Goal: Meat That's Better Than Meat | Tufts Now - Tufts Now - January 30th, 2021
- Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab -... - January 30th, 2021
- Cell and Gene Therapy Market Size to Reach USD 7,250.0 Million by 2028 | Increasing Investments in Production Capacity Expansion for Cell and Gene... - January 30th, 2021
- Protein identified that may help treat Parkinsons disease - Medical News Today - January 30th, 2021
- Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases - Science... - January 30th, 2021
- Elevian Targets Aging to Solve Humanity's Toughest Diseases - BioSpace - January 30th, 2021
- Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor Microenvironment - Business Wire - January 30th, 2021
- Global Stem Cell Reconstructive Market Detailed analysis of current Industry figures with forecasts growth by 2028 | Top Players; Osiris... - January 25th, 2021
- Cell Separation Technologies Market to Reach $28.76 Bn, Globally, by 2027 at 15.4% CAGR, Says Allied Market Research - PRNewswire - January 25th, 2021
- Stem Cell Therapy Market to Witness Increase in Revenues by 2025 NeighborWebSJ - NeighborWebSJ - January 25th, 2021
- Hemostemix Announces the Bread Contract with the Department of Foreign Affairs, Trade & Development Canada - BioSpace - January 23rd, 2021
- Comprehensive Report on Stem Cell Banking Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 |Cordlife, Cryo-Cell... - January 23rd, 2021
- Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism... - January 22nd, 2021
- BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn Derived Exosome-Based Treatment for COVID-19 ARDS -... - January 22nd, 2021
- Regenerative medicine is advancing health care in diverse ways - Hometown Focus - January 22nd, 2021
- Gene Pathway Linked to Development of Schizophrenia - Psychiatric Times - January 22nd, 2021
- Humanigen Announces the Addition of BARDA and Expansion of CRADA with the US Government to Develop Lenzilumab for COVID-19 - BioSpace - January 22nd, 2021
- Cell Sorting Market Size to Reach USD 805.1 Million By 2027 | Expanding Biotechnology And Pharmaceutical Industries will be the Major Factor Driving... - January 22nd, 2021
- BrainStorm's Covid-19 ARDS treatment improves lung function in study - Clinical Trials Arena - January 22nd, 2021
- Impact of Covid-19 on Automated Cell Culture Market Influencing the Industry Development and Forecast | BD, Tecan Trading, Sartorius, TAP Biosystems,... - January 22nd, 2021
- Global Live Cell Imaging Market Size is Expected to reach USD 3529.26 Million by 2025 and Registeri - PharmiWeb.com - January 22nd, 2021
- [Full text] Identification and Targeting of ThomsenFriedenreich and IL1RAP | OTT - Dove Medical Press - January 22nd, 2021
- New Genetic Disorder Discovered That Affects Brain and Craniofacial Skeleton - Technology Networks - January 22nd, 2021
- Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology - PRNewswire - January 22nd, 2021
- Stem cells on the ballot - Science Magazine - January 14th, 2021
- 2021 Startups to Watch: Ronawk's T-Blocks stack the future of stem cell research in an Olathe lab - Startland News - January 14th, 2021
- Towards a Cure: Carleton Research Team Working on Stem Cell Therapy to Reverse Type 1 Diabetes - Carleton Newsroom - January 14th, 2021
- Stem Cell Assay Market | Know the aspects that will serve as game-changers for the market - BioSpace - January 14th, 2021
